This guidance from the ACR provides information about new remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) treatment management codes
The ACR Urges House to Reverse NIH Research Funding Cuts
A bill approved last year by the House Appropriations Committee contains dire cuts to funding for the National Institutes of Health. The ACR is urging the House to revise this language and the Senate not to allow these cuts to go through. Contact your legislators to convey the importance of robust investment in the nation’s medical research enterprise and how funding cuts harm patient care.
Got a Private Practice Question? The Community Practice Council Can Help
ACR members in private practice on The Community Practice Council can answer questions, share experiences and offer encouragement to those interested in private practice.
UnitedHealthcare Working to Correct J Code Reimbursement Error
An error in UnitedHealthcare’s claims processing system resulted in underpayments on J code claims dated Oct. 8–Nov. 8, 2023. Practices are encouraged to review all J code payments from the final quarter of 2023.
Advancing the Work of CORC: Q&A with New Chair Chris Phillips, MD
New Committee on Rheumatologic Care (CORC) Chair Chris Phillips, MD, talks about his past work with the ACR, his experience as a private practice rheumatologist and his plans to lead CORC in addressing practitioner pain points and supporting the business side of rheumatology practice.
Pharmacokinetic Modeling & Efficacy Extrapolation: FDA Takes New Approaches to Drug Approvals
An array of new and expanded indications of therapeutics for rheumatic disease last year relied on pharmacokinetic modeling for intravenous dosing and efficacy extrapolation for pediatric populations.
Updates from AMA House of Delegates 2023 Interim Meeting
Last month, the ACR’s delegation to the AMA House of Delegates discussed and advanced resolutions to address specialty workforce shortages, payment reform and access to care.
Remote Prescribing Exceptions Extended Through 2024
The Department of Health & Human Services and Drug Enforcement Administration have extended through Dec. 31, 2024, exceptions that allow providers to prescribe controlled medications via telemedicine appointments without conducting an in-person evaluation.
Experts Highlight Key Issues Impairing Access to Care
Speakers discussed common payer practices and policies that rheumatologists must navigate to secure and maintain appropriate care for their patients, including pharmacy benefit managers and prior authorization.
Research & Precision Medicine in Community Rheumatology Practices
Rheumatologists in community practices don’t have to abandon their research interests. The Rheumatologist recently interviewed three community practice rheumatologists from around the U.S. to find out their approaches to patient management, staffing and other areas of the practice. Here, they discuss their approach to incorporating research into their practice. At New England Rheumatology & Osteoporosis,…
- « Previous Page
- 1
- …
- 39
- 40
- 41
- 42
- 43
- …
- 332
- Next Page »